As of Feb 03, 2025, Johnson & Johnson Intrinsic Value is $193.7. This suggests it may be undervalued by 27.5% compared to its current price of around $151.9.
As of Feb 03, 2025, Johnson & Johnson's Discounted Cash Flow (DCF) valuation estimates its share price at $227.8. This suggests it may be overvalued by 50.0% to its current price of around $151.9, using a discount rate of 7.1% and terminal growth rate of 3.0%.
Johnson & Johnson is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $193.7, compared to a market price of around $151.9. This suggests a potential undervaluation of 27.5%.